CA985172A - Compositions and methods for reducing blood cholesterol - Google Patents

Compositions and methods for reducing blood cholesterol

Info

Publication number: CA985172A
Authority: CA; Canada
Prior art keywords: compositions; methods; reducing blood; blood cholesterol; cholesterol
Prior art date: 1972-10-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA153,515A

Other versions

CA153515S (en

Inventor

Dushan M. Dvornik

Mitchell N. Cayen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wyeth LLC

Original Assignee

American Home Products Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-10-06

Filing date

1972-10-06

Publication date

1976-03-09

1972-10-06 Application filed by American Home Products Corp filed Critical American Home Products Corp

1972-10-06 Priority to CA153,515A priority Critical patent/CA985172A/en

1973-09-11 Priority to ZA00737246A priority patent/ZA737246B/en

1973-09-17 Priority to US398130A priority patent/US3890438A/en

1973-09-24 Priority to IE1698/73A priority patent/IE38274B1/en

1973-09-25 Priority to DE19732348176 priority patent/DE2348176A1/en

1973-10-01 Priority to IN2210/CAL/73A priority patent/IN138921B/en

1973-10-02 Priority to NL7313519A priority patent/NL7313519A/xx

1973-10-03 Priority to BE136318A priority patent/BE805634A/en

1973-10-04 Priority to HUAE394A priority patent/HU169814B/hu

1973-10-05 Priority to DD173898A priority patent/DD106948A5/xx

1973-10-05 Priority to CS736877A priority patent/CS197387B1/en

1973-10-05 Priority to ES419355A priority patent/ES419355A1/en

1973-10-05 Priority to SE7313618A priority patent/SE403886B/en

1973-10-05 Priority to GB4656473A priority patent/GB1439625A/en

1973-10-05 Priority to FR7335748A priority patent/FR2201893B1/fr

1973-10-08 Priority to AU61108/73A priority patent/AU477269B2/en

1976-03-09 Application granted granted Critical

1976-03-09 Publication of CA985172A publication Critical patent/CA985172A/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

CA153,515A 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol Expired CA985172A (en)

Priority Applications (16)

Application Number	Priority Date	Filing Date	Title
CA153,515A CA985172A (en)	1972-10-06	1972-10-06	Compositions and methods for reducing blood cholesterol
ZA00737246A ZA737246B (en)	1972-10-06	1973-09-11	Compositions and methods for reducing blood cholesterol
US398130A US3890438A (en)	1972-10-06	1973-09-17	Compositions and methods for reducing blood cholesterol
IE1698/73A IE38274B1 (en)	1972-10-06	1973-09-24	Compositions for reducing blood cholesterol
DE19732348176 DE2348176A1 (en)	1972-10-06	1973-09-25	MEDICINAL PRODUCTS FOR LOWERING BLOOD CHOLESTEROL LEVELS
IN2210/CAL/73A IN138921B (en)	1972-10-06	1973-10-01
NL7313519A NL7313519A (en)	1972-10-06	1973-10-02
BE136318A BE805634A (en)	1972-10-06	1973-10-03	COMPOSITIONS AND METHODS FOR LOWERING THE BLOOD CHOLESTEROL LEVEL
HUAE394A HU169814B (en)	1972-10-06	1973-10-04
DD173898A DD106948A5 (en)	1972-10-06	1973-10-05
CS736877A CS197387B1 (en)	1972-10-06	1973-10-05	Pharmaceutical mixture for decreasing the cholesterole level in the blood
ES419355A ES419355A1 (en)	1972-10-06	1973-10-05	Compositions and methods for reducing blood cholesterol
SE7313618A SE403886B (en)	1972-10-06	1973-10-05	PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD CHOLESTEROL LEVELS
GB4656473A GB1439625A (en)	1972-10-06	1973-10-05	Compositions for reducing blood cholesterol
FR7335748A FR2201893B1 (en)	1972-10-06	1973-10-05
AU61108/73A AU477269B2 (en)	1972-10-06	1973-10-08	Compositions and methods for reducing blood cholesterol

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA153,515A CA985172A (en)	1972-10-06	1972-10-06	Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number	Publication Date
CA985172A true CA985172A (en)	1976-03-09

Family

ID=4094630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA153,515A Expired CA985172A (en)	1972-10-06	1972-10-06	Compositions and methods for reducing blood cholesterol

Country Status (16)

Country	Link
US (1)	US3890438A (en)
AU (1)	AU477269B2 (en)
BE (1)	BE805634A (en)
CA (1)	CA985172A (en)
CS (1)	CS197387B1 (en)
DD (1)	DD106948A5 (en)
DE (1)	DE2348176A1 (en)
ES (1)	ES419355A1 (en)
FR (1)	FR2201893B1 (en)
GB (1)	GB1439625A (en)
HU (1)	HU169814B (en)
IE (1)	IE38274B1 (en)
IN (1)	IN138921B (en)
NL (1)	NL7313519A (en)
SE (1)	SE403886B (en)
ZA (1)	ZA737246B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3838716A1 (en) *	1988-11-15	1990-05-17	Kanoldt Arzneimittel Gmbh	MEDICINAL PRODUCTION OF ESTER DERIVATIVES OF HECOGENINE AND ITS USE FOR THE TREATMENT OF BENIGNER PROSTATE HYPERPLASIA
US6929807B1 (en) *	1996-08-09	2005-08-16	Mannatech, Inc.	Compositions of plant carbohydrates as dietary supplements
GB9923076D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
US20030118673A1 (en) *	1998-03-26	2003-06-26	Zongqin Xia	Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
PL195897B1 (en) *	1998-03-26	2007-11-30	Phytopharm Plc	Membrane-bound receptors and their function; cognitive disfunction; treatments therefor; and compositions for use in such treatments
GB2347676A (en) *	1999-03-08	2000-09-13	Phytopharm Plc	Screening method
GB9923078D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
GB9923077D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
GB0000228D0 (en) *	2000-01-06	2000-03-01	Phytopharm Plc	Fluoro substituted sapogenins and their use
GB0107822D0 (en) *	2001-03-28	2001-05-23	Phytopharm Plc	Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (en) *	2001-08-24	2003-03-20	Jilin Tianyao Science And Technology Co. Ltd.	USE OF 3β-HYDROXY-5-SPIROSTENE AS DRUGS FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES OR CONDITIONS FOR INHIBITION OF TUMORS AND DECREASING OF BLOOD LIPIDS
CN102727501A (en) *	2002-03-27	2012-10-17	菲特法姆股份有限公司	Uses of sapogenins and their derivatives
US20050130948A1 (en) *	2002-03-27	2005-06-16	Daryl Rees	Therapeutic methods and uses of sapogenins and their derivatives
AU2003231427A1 (en) *	2002-04-15	2003-10-27	Chengdu Di'ao Pharmaceutical Group Co., Ltd.	Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
GB0409567D0 (en)	2004-04-28	2004-06-02	Phytopharm Plc	Chemical compounds
US20090209489A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090209486A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions of carbohydrates as dietary supplements
US20090209488A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions for the treatment of exercise induced asthma
US20090208588A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	GERD carbohydrate compositions
MX2013000760A (en)	2010-07-20	2013-10-28	Phytopharm Plc	Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders.
FR3133158A1 (en)	2022-03-04	2023-09-08	Psa Automobiles Sa	METHOD FOR ENERGY MANAGEMENT OF AN ACCESSORY POWER SOCKET IN A STATIONARY MOTOR VEHICLE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE630211A (en) *	1962-03-28

1972
- 1972-10-06 CA CA153,515A patent/CA985172A/en not_active Expired
1973
- 1973-09-11 ZA ZA00737246A patent/ZA737246B/en unknown
- 1973-09-17 US US398130A patent/US3890438A/en not_active Expired - Lifetime
- 1973-09-24 IE IE1698/73A patent/IE38274B1/en unknown
- 1973-09-25 DE DE19732348176 patent/DE2348176A1/en active Pending
- 1973-10-01 IN IN2210/CAL/73A patent/IN138921B/en unknown
- 1973-10-02 NL NL7313519A patent/NL7313519A/xx not_active Application Discontinuation
- 1973-10-03 BE BE136318A patent/BE805634A/en unknown
- 1973-10-04 HU HUAE394A patent/HU169814B/hu unknown
- 1973-10-05 CS CS736877A patent/CS197387B1/en unknown
- 1973-10-05 FR FR7335748A patent/FR2201893B1/fr not_active Expired
- 1973-10-05 ES ES419355A patent/ES419355A1/en not_active Expired
- 1973-10-05 DD DD173898A patent/DD106948A5/xx unknown
- 1973-10-05 SE SE7313618A patent/SE403886B/en unknown
- 1973-10-05 GB GB4656473A patent/GB1439625A/en not_active Expired
- 1973-10-08 AU AU61108/73A patent/AU477269B2/en not_active Expired

Also Published As

Publication number	Publication date
IE38274B1 (en)	1978-02-01
ZA737246B (en)	1975-04-30
CS197387B1 (en)	1980-05-30
GB1439625A (en)	1976-06-16
FR2201893B1 (en)	1977-09-09
ES419355A1 (en)	1976-03-01
NL7313519A (en)	1974-04-09
HU169814B (en)	1977-02-28
BE805634A (en)	1974-04-03
IN138921B (en)	1976-04-17
FR2201893A1 (en)	1974-05-03
SE403886B (en)	1978-09-11
AU477269B2 (en)	1976-10-21
US3890438A (en)	1975-06-17
AU6110873A (en)	1975-04-10
DD106948A5 (en)	1974-07-12
IE38274L (en)	1974-04-06
DE2348176A1 (en)	1974-04-11

Publication	Publication Date	Title
CA985172A (en)	1976-03-09	Compositions and methods for reducing blood cholesterol
AU463065B2 (en)	1975-07-17	Oximeter and method
CA1028953A (en)	1978-04-04	Compositions and methods for depressing blood serum cholesterol
AU470415B2 (en)	1976-03-18	Composition and process
CA1003631A (en)	1977-01-18	Antiozonant-antioxidant composition and process for preparation thereof
CA1023665A (en)	1978-01-03	Dermatological composition and method
AU468257B2 (en)	1976-01-08	Novel steroids and compositions
CA1014559A (en)	1977-07-26	Amino-imidazo and amino-pyrazolo-isoquinolines and process for the preparation thereof
AU471942B2 (en)	1976-05-06	Composition and process
CA1026334A (en)	1978-02-14	Nitroimidazolyl-triazolo-pyridazines and process for their preparation
AU5815373A (en)	1975-01-16	Compositions and methods
CA903429A (en)	1972-06-27	Method and compositions for cable-blocking
CA902628A (en)	1972-06-13	Silylorganocarbamates and preparation
CA893251A (en)	1972-02-15	Diagnostic composition and process
CA902474A (en)	1972-06-13	Process and diagnostic composition
CA903651A (en)	1972-06-27	Cholesterol determination
CA856831A (en)	1970-11-24	Cholesterol lowering agent and its preparation
CA850646A (en)	1970-09-01	Cholesterol lowering agent and its preparation
CA845160A (en)	1970-06-23	Cholesterol lowering agent and its preparation
CA908322A (en)	1972-08-22	Mattresses for clinical and other uses
CA1022290A (en)	1977-12-06	Copolymer-phyliosilicate composition and process therefor
CA909790A (en)	1972-09-12	Bis-chromonyl compounds and methods for their preparation
CA905057A (en)	1972-07-18	Fabric-stiffening composition and process
AU5144169A (en)	1970-09-10	Composition for lowering cholesterol blood
AU6606769A (en)	1971-07-01	Compositions and method for lowering blood cholesterol level